We passionately improve health
Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies.
Explore Our Content
-
-
Management
New Member of the Board of Managing Directors of Boehringer Ingelheim/ Responsible for Corporate Board Division Finance
-
Acute Ischaemic Stroke
We want to improve acute stroke care by building a community of 1,500 stroke centres and stroke ready hospitals by May 2019
-
Making More Health
-
Partnering
Partnerships are important in creating innovation. Read more about Dr Paola Casarosa and her work on developing therapeutic alliances and strategic partnerships.
-
-
How We Discover
From initial discovery to a marketable medicine is a long, challenging road. It takes about 12 - 15 years from discovery to the approved medication and requires an investment of about US $1 billion.